| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |